Human Genome Epidemiology Literature Finder
Records 1 - 10 (of 10 Records) |
Query Trace: Breast Neoplasms and CCL2[original query] |
---|
Chemokine-enhanced chemotaxis of lymphangioleiomyomatosis cells with mutations in the tumor suppressor TSC2 gene. Journal of immunology (Baltimore, Md. : 1950) 2009 Feb 182 (3): 1270-7. Pacheco-Rodriguez Gustavo, Kumaki Fumiyuki, Steagall Wendy K, Zhang Yi, Ikeda Yoshihiko, Lin Jing-Ping, Billings Eric M, Moss Jo |
CCL2 -2518 A/G single nucleotide polymorphism as a risk factor for breast cancer. Molecular biology reports 2011 Feb 38 (2): 1263-7. Kruszyna Lukasz, Lianeri Margarita, Rubis B?a?ej, Knu?a Hanna, Rybczy?ska Maria, Grodecka-Gazdecka Sylwia, Jagodzi?ski Pawe? |
Innate immunity pathways and breast cancer Risk in African American and European-American women in the Women's Circle of Health Study (WCHS). PloS one 2013 8 (8): e72619. Gong Zhihong, Quan Lei, Yao Song, Zirpoli Gary, Bandera Elisa V, Roberts Michelle, Coignet Jean-Gabriel, Cabasag Citadel, Sucheston Lara, Hwang Helena, Ciupak Gregory, Davis Warren, Pawlish Karen, Jandorf Lina, Bovbjerg Dana H, Ambrosone Christine B, Hong Chi-Ch |
Host genotype and tumor phenotype of chemokine decoy receptors integrally affect breast cancer relapse. Oncotarget 2015 Jul . Yu Ke-Da, Wang Xin, Yang Chen, Zeng Xiao-Hua, Shao Zhi-Mi |
Single nucleotide polymorphisms might influence chemotherapy induced nausea in women with breast cancer. Clinical and translational radiation oncology 2018 4 2 1-6. Oliva Delmy, Nilsson Mats, Andersson Bengt-Åke, Sharp Lena, Lewin Freddi, Laytragoon-Lewin Nongn |
The rs1024611 in the CCL2 gene and risk of gynecological cancer in Asians: a meta-analysis. World journal of surgical oncology 2018 Feb 16 (1): 34. He Shuying, Zhang Xiuzh |
Atypical Chemokine Receptor 1 (DARC/ACKR1) in Breast Tumors Is Associated with Survival, Circulating Chemokines, Tumor-Infiltrating Immune Cells, and African Ancestry. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2019 4 28 (4): 690-700. Jenkins Brittany D, Martini Rachel N, Hire Rupali, Brown Andrea, Bennett Briana, Brown I'nasia, Howerth Elizabeth W, Egan Mary, Hodgson Jamie, Yates Clayton, Kittles Rick, Chitale Dhananjay, Ali Haythem, Nathanson David, Nikolinakos Petros, Newman Lisa, Monteil Michele, Davis Melissa |
The Influence of Single Nucleotide Polymorphisms and Adjuvant Radiotherapy on Systemic Inflammatory Proteins, Chemokines and Cytokines of Patients With Breast Cancer. Anticancer research 2019 Mar 39 (3): 1287-1292. Lewin Nongnit Laytragoon, Luetragoon Thitiya, Andersson Bengt-Åke, Oliva Delmy, Nilsson Mats, Strandeus Michael, Löfgren Sture, Rutqvist Lars-Erik, Lewin Fred |
Single Nucleotide Polymorphism Directed Antiemetic Treatment in Women With Breast Cancer Treated With Neo- or Adjuvant Chemotherapy: A Randomised Multicentre Phase II Study. (EudraCT: 2015-000658-39). Anticancer research 2023 5 43 (6): 2671-2681. Delmy Oliva, Bengt-Åke Andersson, Levar Shamoun, Nongnit Lewin, Mats P Nilsson, Elsy-Britt Schildt, Lisa Fust, Ulrika Åsenlund, Gunilla Sellerstam, Ellinor Elinder, Lena Sharp, Freddi Lew |
Expression of immune-related genes and breast cancer recurrence in women with ductal carcinoma in situ. European journal of cancer (Oxford, England : 1990) 2024 4 203 114063. Elena Guerini-Rocco, Federica Bellerba, Alberto Concardi, Sergio Vincenzo Taormina, Giulio Cammarata, Caterina Fumagalli, Aliana Guerrieri-Gonzaga, Debora Macis, Eliza Del Fiol Manna, Emanuela Balladore, Maria Cannone, Paolo Veronesi, Nicola Fusco, Bernardo Bonanni, Giuseppe Viale, Massimo Barberis, Sara Gandini, Matteo Lazzero |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: